Oxidative Stress in Genitourinary Cancer
Publisher
Springer Singapore
Reference53 articles.
1. Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA (2019) Systematic review of modifiable risk factors for kidney cancer. Urol Oncol 37:359–371. https://doi.org/10.1016/j.urolonc.2018.12.008
2. Alberghini A, Recalcati S, Tacchini L, Santambrogio P, Campanella A, Cairo G (2005) Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells. J Biol Chem 280:30120–30128. https://doi.org/10.1074/jbc.M500971200
3. Amasyali AS, Kucukgergin C, Erdem S, Sanli O, Seckin S, Nane I (2012) Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases. J Urol 188:2398–2403. https://doi.org/10.1016/j.juro.2012.07.096
4. Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E et al (2018) The long tail of oncogenic drivers in prostate cancer. Nat Genet 50:645–651. https://doi.org/10.1038/s41588-018-0078-z
5. Audenet F, Attalla K, Sfakianos JP (2018) The evolution of bladder cancer genomics: what have we learned and how can we use it? Urol Oncol 36:313–320. https://doi.org/10.1016/j.urolonc.2018.02.017